Sign up to save your podcasts
Or
Share Prof. dr. Michael Boyer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Prof. dr. Michael Boyer
In this podcast, Professor Michael Boyer discusses the Keynote 598 trial and what these results mean for the future of dual immunotherapy combinations.
View all episodes
By Ariez PublishingIn this podcast, Professor Michael Boyer discusses the Keynote 598 trial and what these results mean for the future of dual immunotherapy combinations.